PTC Therapeutics - Company & Market Research Reports

Home /
Companies /
PTC Therapeutics

PTC Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The company's lead product candidate is Translarna (ataluren), which is for the treatment of of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. It is currently in Phase III clinical trials to treat cystic fibrosis caused by nonsense mutations. The company was founded in 1998 and is headquartered in South Plainfield, New Jersey.

REFINE BY

KEYWORD

Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
September 2022
799 Pages
Global

From

€4706EUR$4,799USD£3,921GBP

Phenylketonuria (PKU) (Metabolic Disorder) - Drugs in Development, 2021

 Drug Pipelines
March 2021
Global

From

€1961EUR$2,000USD£1,634GBP

Cystic Fibrosis Market by Drug Class, Route of Administration - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Huntington Disease - Pipeline Review, H1 2020

 Drug Pipelines
June 2020
390 Pages
Global

From

€1961EUR$2,000USD£1,634GBP

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

 Report
September 2022
194 Pages
Global

From

€4706EUR$4,799USD£3,921GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Regional Outlook and Forecast, 2022 - 2028

 Report
August 2022
308 Pages
Global

From

€3530EUR$3,600USD£2,942GBP

Cystic Fibrosis (CF) Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

 Report
May 2019
385 Pages
Global

From

€4412EUR$4,499USD£3,676GBP

Phenylketonuria Treatment Market by Route of Administration, Product, Distribution - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Angelman Syndrome - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1030EUR$1,050USD£858GBP

€1471EUR$1,500USD£1,226GBP

Cystic Fibrosis Treatment Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€5883EUR$5,999USD£4,902GBP

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - USA Edition - The Views of 314 USA Patient Groups

 Report
May 2024
50 Pages
United States

€10185EUR$10,750USD£8,200GBP

The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide

 Report
April 2024
138 Pages
Global

€31053EUR$32,776USD£25,000GBP

Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2024

 Clinical Trials
January 2024
90 Pages
Global

From

€1030EUR$1,050USD£858GBP

€1471EUR$1,500USD£1,226GBP

Gastroparesis - Pipeline Insight, 2024

 Clinical Trials
April 2024
50 Pages
Global

From

€1030EUR$1,050USD£858GBP

€1471EUR$1,500USD£1,226GBP

Europe Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
120 Pages
Europe

From

€1471EUR$1,500USD£1,226GBP

North America Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
104 Pages
North America

From

€1471EUR$1,500USD£1,226GBP

Asia Pacific Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
121 Pages
Asia Pacific

From

€1471EUR$1,500USD£1,226GBP

LAMEA Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
121 Pages
Middle East, Africa

From

€1471EUR$1,500USD£1,226GBP

Alpha Mannosidosis Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

117 Results (Page 5 of 6)
- 1
- 3
- 4
- 5
- 6

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.